Single-Dose, Randomized, Crossover Bioequivalence Study of Amlodipine Maleate versus Amlodipine Besylate in Healthy Volunteers

References

• Mosby's Drug Consult, D Nissen. Elsevier Science, St. Louis, Mo 2003, III-157.
   Google Scholar
• DRUGDEX System, TA Hutchison, DR Shahan. MICROMEDEX, Greenwood Village, Colorado 2003; 115
   Google Scholar
• Burges R, Moisey D. Unique pharmacologic properties of amlodipine. Am J Cardiol. 1994; 73: 2A–9A
   PubMed Web of Science ®Google Scholar
• Salhanick S, Shannon MW. Management of calcium antagonist overdose. Drug Safety. 2003; 26: 65–79
   PubMed Web of Science ®Google Scholar
• Mason RP, Marche P, Hintze TH. Novel vascular biology of third-generation L-type calcium channel antagonists: Ancillary actions of amlodipine. Arterioscler Thromb Vasc Biol. 2003; 23: 2155–2163
   PubMed Web of Science ®Google Scholar
• Park S, Chung N, Kwon J, Yoon JH, Kim YJ, Han DS, Kim HS. Results of a multicenter, eight-week, parallel-group, randomized, double-blind, double-dummy, Phase III clinical trial to evaluate the efficacy and tolerability of amlodipine maleate versus amlodipine besylate in Korean patients with mild to moderate hypertension. Clin Ther. 2005; 27: 441–450
   PubMed Web of Science ®Google Scholar
• New amlodipine (Amloc) product available in South Africa. Cardiovasc J S Afr. 2005; 16: 61
   Google Scholar
• Park JY, Kim KA, Lee GS, Park PW, Kim SL, Lee YS, Lee YW, Shin EK. Randomized, open-label, two-period crossover comparison of the pharmacokinetic and pharmacodynamic properties of two amlodipine formulations in healthy adult male Korean subjects. Clin Ther. 2004; 26: 715–723
   PubMed Web of Science ®Google Scholar
• Hong SJ, Ahn TH, Baek SH, Cho WH, Jeon HK, Kyun J, Yoon MH, Lee KJ, Lim DS. Comparison of efficacy and tolerability of amlodipine orotate versus amlodipine besylate in adult patients with mild to moderate hypertension: A multicenter, randomized, double-blind, placebo-controlled, parallel-group, eight-week follow-up, noninferiority trial. Clin Ther. 2006; 28: 537–551
   PubMed Web of Science ®Google Scholar
• Recepimento delle linee guida dell'U.E. di Buona Pratica Clinica per la esecuzione delle sperimentazioni cliniche dei medicinali. Gazzetta Ufficiale della Repubblica Italiana 1997; 15: 139, Jun
   Google Scholar
• Faulkner JK, McGibney D, Chasseaud LF, Perry JL, Taylor IW. The pharmacokinetics of amlodipine in healthy volunteers after single intravenous and oral doses and after 14 repeated oral doses given once daily. Br J Clin Pharmacol. 1986; 22: 21–25
   PubMed Web of Science ®Google Scholar
• Westlake W. Use of confidence intervals in analysis of comparative bioavailability trials. J Pharm Sci. 1972; 6: 1340–1341
   Google Scholar
• Schuirmann DJ. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J Pharmacokin Biopharm. 1987; 15: 657–680
   PubMedGoogle Scholar
• Hauschke D, Steinijans VW, Diletti E. A distribution free procedure for the statistical analysis of bioequivalence studies. Int J Clin Pharmacol Ther Toxicol. 1990; 28: 72–78
   PubMed Web of Science ®Google Scholar
• Steinijans VW, Hauschke D. Update on the statistical analysis of bioequivalence studies. Int J Clin Pharmacol Ther Toxicol. 1992; 28: 105–110
   Google Scholar
• Phillips KF. Power of the two one-sided tests procedure in bioequivalence. J Pharmacokinet Biopharm. 1990; 18: 137–144
   PubMedGoogle Scholar
• Chow SC, Liu JP. Design and Analysis of Bioavailability and Bioequivalence Studies. Marcel Dekker Inc, New York 1992
   Google Scholar
• Sauter R, Steinijans VW, Diletti E. Presentation of results from bioequivalence studies. Int J Clin Pharmacol Ther Toxicol. 1992; 30: 233–256
   PubMedGoogle Scholar
• Midha KK, Rawson MJ, Hubbard JW. The bioequivalence of highly variable drugs and drug products. Int J Clin Pharmacol Ther. 2005; 43: 485–498
   PubMed Web of Science ®Google Scholar
• Health Canada. Guidance for Industry: Conduct and Analysis of Bioavailability and Bioequivalence Studies—Part A: Oral Dosage Formulations Used for Systemic Effects. Ministry of Health, Ottawa, OntarioCanada 1992
   Google Scholar
• Japan National Institute of Health, Division of Drugs. Guideline for Bioequivalence Studies of Generic Drug Products. NIH Japan, Tokyo 1997
   Google Scholar
• Medicines Control Council, Department of Health, Republic of South Africa. Registration of Medicines: Biostudies. MCC, PretoriaSouth Africa 2003
   Google Scholar
• Burges R, Moisey D. Unique pharmacologic properties of amlodipine. Am J Cardiol. 1994; 73: 2A–9A
   PubMed Web of Science ®Google Scholar
• PA van Zwieten. Amlodipine: an overview of its pharmacodynamic and pharmacokinetics properties. Clin Cardiol. 1994; 17: 3–6
   PubMed Web of Science ®Google Scholar
• Godfraind T, Mennig D, Bravo G, Chalant C, Jaumin P. Inhibition by amlodipine of activity evoked in isolated human coronary arteries by endothelin, prostaglandin F2 alpha and depolarization. Am J Cardiol. 1989; 64: 58I–64I
   PubMed Web of Science ®Google Scholar
• Pascual J. Hypertension control in the elderly with amlodipine. Curr Med Res Opin. 2000; 16: 33–36
   PubMed Web of Science ®Google Scholar
• Nayler WG, Gu XH. Vascular and myocardial effects of amlodipine: An overview. Postgrad Med J 1991; 67: S41–S43
   PubMed Web of Science ®Google Scholar
• Marzo A, Dal Bo L, Mazzucchelli P, Monti NC, Crivelli F, Ismaili S, Uhr MR, La Commare P. Amlodipine bioequivalence achieved with a very sensitive liquid chromatography tandem mass spectrometric bioassay. Arzneimittelforschung. 2000; 50: 688–694
   PubMed Web of Science ®Google Scholar
• Carvalho M, Oliveira CH, Mendes GD, Sucupira M, Moraes ME, De Nucci G. Amlodipine bioequivalence study: Quantification by liquid chromatography coupled to tandem mass spectrometry. Biopharm Drug Dispos. 2001; 22: 383–390
   PubMed Web of Science ®Google Scholar
• Rojanasthien N, Teekachunhatean S, Jakob K, Gaupp M, Arnold P, Chaichana N, Martin W. Bioequivalence study of generic amlodipine in healthy Thai male volunteers. Int J Clin Pharmacol Ther. 2004; 42: 330–335
   PubMed Web of Science ®Google Scholar
• Abad-Santos F, Novalbos J, Galvez-Mugica MA, Gallego-Sandin S, Almeida S, Vallee F, Garcia AG. Assessment of sex differences in pharmacokinetics and pharmacodynamics of amlodipine in a bioequivalence study. Pharmacol Res. 2005; 51: 445–452
   PubMed Web of Science ®Google Scholar